脊柱疾病治疗解决方案提供商Companion Spine将从Xtant Medical收购Paradigm Spine的资产-动脉网

Companion Spine to acquire Paradigm Spine assets from Xtant Medical

Medical Device Network 等信源发布 2025-07-09 10:28



可切换为仅中文







The acquisition will allow Companion Spine to widen its aim to treat spine pain through lumbar and cervical disease treatment. Credit: sweet_tomato / Shutterstock.

收购将使Companion Spine能够扩大其治疗腰椎和颈椎疾病引起的脊柱疼痛的目标。来源：sweet_tomato / Shutterstock。

French-American spine pain-management surgery specialist Companion Spine has entered a definitive agreement to acquire the Coflex Interlaminar Stabilization device (Corflex), CoFix Posterior MIS fusion system (CoFix) implants, along with Paradigm Spine’s business and assets, from Xtant Medical Holdings..

法国-美国脊柱疼痛管理手术专家Companion Spine已与Xtant Medical Holdings达成最终协议，将收购Coflex椎板间稳定装置（Corflex）、CoFix后路微创融合系统（CoFix）植入物，以及Paradigm Spine的业务和资产。

The $19.2m transaction includes $11m in cash at closing and $8.2m in short-term seller financing.

这笔1920万美元的交易包括在成交时支付1100万美元现金和820万美元的短期卖方融资。

Go deeper with GlobalData

深入了解更多全球数据

Reports

报告

Medical Devices Industry Mergers and Acquisitions Deals by Top Them...

医疗器械行业并购交易的主题分布

Reports

报告

Bone Grafts and Substitutes Market Size (Value, Volume, ASP) by Seg...

骨移植和替代品市场规模（价值、数量、平均售价）按细分...

Data Insights

数据洞察

The gold standard of business intelligence.

商业智能的黄金标准。

Find out more

了解更多

Xtant Medical plans to utilise the proceeds to decrease its long-term debt and increase cash liquidity.

Xtant Medical计划利用这笔资金减少长期债务并增加现金流动性。

The closure of the transaction is slated in the third quarter of this year, subject to Companion Spine securing financing and meeting other customary closing conditions.

该交易预计将在今年第三季度完成，但需 Companion Spine 获得融资并满足其他惯例成交条件。

As part of the agreement, Companion Spine has already paid Xtant a non-refundable cash deposit of $2.5m of the aggregated purchase price.

作为协议的一部分，Companion Spine 已向 Xtant 支付了 250 万美元的不可退还现金定金，作为总购买价格的一部分。

Up to two additional deposits of the same amount may be made if Companion Spine needs more time to receive financing.

如果Companion Spine需要更多时间来获得融资，可以再进行两次相同金额的额外存款。

GlobalData Strategic Intelligence

全球数据战略情报

US Tariffs are shifting - will you react or anticipate?

美国关税正在变化——你会做出反应还是提前预料？

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

不要让政策变化让你措手不及。通过实时数据和专家分析保持主动性。

By GlobalData

全球数据

Learn more about Strategic Intelligence

了解有关战略情报的更多信息

At or before closing, Companion Spine will pay an additional $8.5m, alongside an $8.2m unsecured promissory note.

在或之前收盘时，Companion Spine将额外支付850万美元，同时附上一张820万美元的无担保本票。

The Coflex and CoFix systems have been marketed by Paradigm Spine in the US for 12 years and outside the US for 20 years.

Coflex和CoFix系统已经由Paradigm Spine公司在美国市场销售了12年，在美国以外的市场销售了20年。

Headquartered in Germany, Paradigm Spine is focused on designing, developing, marketing, and distributing spine implant solutions for spine pain-related disorders.

总部位于德国，Paradigm Spine 专注于设计、开发、营销和分销针对脊柱疼痛相关疾病的脊柱植入解决方案。

The acquisition is claimed to enable Companion Spine to become the “first” sole source provider of a full range of indication-specific products for dynamic stabilisation and motion preservation implants. Furthermore, the deal will allow Companion Spine to widen its aim to treat spine pain through lumbar and cervical disease treatments..

该收购案声称能使Companion Spine成为“首家”提供全系列针对特定适应症的动态稳定和运动保留植入物的唯一供应商。此外，这笔交易将使Companion Spine能够扩大其目标，通过腰椎和颈椎疾病治疗来缓解脊柱疼痛。

Advisers involved in this acquisition for Companion Spine include Dorsey & Whitney as lead legal counsel, McDermott Will & Emery for tax and German legal matters, Farber for intellectual property legal counsel, and several other financial, strategic, and regulatory advisers.

参与此次 Companion Spine 收购的顾问包括 Dorsey & Whitney 担任首席法律顾问，McDermott Will & Emery 负责税务和德国法律事务，Farber 担任知识产权法律顾问，以及其他若干财务、战略和监管顾问。

Fox Rothschild served as legal counsel and LifeSci Partners as investor relations advisor for Xtant.

福克斯·罗斯柴尔德担任Xtant的法律顾问，LifeSci Partners担任投资者关系顾问。

Xtant Medical CEO and president Sean Browne said: “This transaction is a significant step for us as we focus on our core business – the development of higher-margin, best-in-class orthobiologics – while also strengthening our balance sheet and streamlining our operations.

Xtant Medical首席执行官兼总裁肖恩·布朗表示：“此次交易是我们专注于核心业务的重要一步——即开发高利润、同品类中最佳的骨生物制品，同时也增强了我们的资产负债表并简化了运营。”

“At the same time, these franchises will be in great hands given the Viscogliosi Brothers’ proven track record of successful commercial execution in the neuro-musculoskeletal space. We believe they, along with Companion Spine, are the ideal partners to continue driving the growth of Coflex, CoFix, HPS, and related spinal fixation technologies.”.

“同时，鉴于Viscogliosi兄弟在神经肌肉骨骼领域成功的商业执行记录，这些特许经营权将会得到很好的管理。我们相信他们与Companion Spine一起，是推动Coflex、CoFix、HPS及相关脊柱固定技术持续增长的理想合作伙伴。”

Companion Spine is a company within the portfolio of Viscogliosi Brothers, an investment company owned by a family that focuses on the neuro-musculoskeletal industry.

Companion Spine 是一家隶属于 Viscogliosi Brothers 投资公司的企业，Viscogliosi Brothers 是一家家族所有的投资公司，专注于神经肌肉骨骼行业。

In 2023, Xtant Medical

2023年，Xtant Medical

completed the acquisition

完成了收购

of the Coflex and Cofix product portfolio from Surgalign Holdings for $17m.

Surgalign Holdings以1700万美元收购了Coflex和Cofix产品组合。

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

利用我们领先的行业洞察，为您的业务提供优势。

Medical Device Network Excellence Awards - Have you nominated?

医疗器械网络卓越奖——你提名了吗？